this invention relates to the use of certain substituted pyrrolo - pyrimidine nucleosides in the treatment of viral infections , in particular those caused by human immunodeficiency virus type 1 , herpes simplex virus type 1 and human cytomegalovirus . these substituted compounds retain antiviral properties present in their parent compounds yet exhibit significantly decreased levels of cytotoxicity .